@ARTICLE{
author={Van Cutsem Eric,Hidalgo Manuel,Canon Jean-Luc,Macarulla Teresa,Bazin Igor,Poddubskaya Elena,Manojlovic Nebojsa S,Radenkovic Dejan V,Verslype Chris,Eric Raymond,Cubillo Antonio,Schueler Armin,Zhao Charles,Hammel Pascal},
year={2018},
title={Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer},
journal={INTERNATIONAL JOURNAL OF CANCER},
volume={143},
number={8},
pages={2053-2064},
document_type={Article},
} 

@ARTICLE{
author={Van Cutsem Eric,Hidalgo Manuel,Bazin Igor,Canon Jean-Luc,Poddubskaya Elena,Manojlovic Nebojsa S,Milella Michele,Radenkovic Dejan V,Verslype Chris,Guo Wei,Damstrup Lars,Hammel Pascal},
year={2015},
title={Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={33},
number={3},
pages={-},
document_type={Meeting Abstract},
}